ITOS logo

ITeos Therapeutics (ITOS) EBITDA

Annual EBITDA

-$153.09 M
-$9.10 M-6.32%

December 31, 2024


Summary


Performance

ITOS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITOSprofitabilitymetrics:

Quarterly EBITDA

-$47.78 M
-$84.00 K-0.18%

December 31, 2024


Summary


Performance

ITOS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITOSprofitabilitymetrics:

TTM EBITDA

-$153.09 M
-$10.76 M-7.56%

December 31, 2024


Summary


Performance

ITOS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITOSprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ITOS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.3%-0.2%-7.6%
3 y3 years-159.9%-122.3%-159.9%
5 y5 years-575.6%-677.8%-575.6%

ITOS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-159.9%at low-122.3%at low-136.3%+7.5%
5 y5-year-159.9%at low-122.3%at low-136.3%+7.5%
alltimeall time-159.9%at low-122.3%at low-136.3%+7.5%

ITeos Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$153.09 M(+6.3%)
-$47.78 M(+0.2%)
-$153.09 M(+7.6%)
Sep 2024
-
-$47.69 M(+283.4%)
-$142.33 M(+4.2%)
Jun 2024
-
-$12.44 M(-72.5%)
-$136.64 M(-17.4%)
Mar 2024
-
-$45.18 M(+22.0%)
-$165.41 M(+15.0%)
Dec 2023
-$143.99 M(-210.4%)
-$37.02 M(-11.9%)
-$143.87 M(+63.7%)
Sep 2023
-
-$42.01 M(+1.9%)
-$87.86 M(+46.1%)
Jun 2023
-
-$41.21 M(+74.4%)
-$60.16 M(+301.7%)
Mar 2023
-
-$23.63 M(-224.5%)
-$14.98 M(-111.5%)
Dec 2022
$130.39 M(-49.0%)
$18.99 M(-232.8%)
$130.39 M(-60.0%)
Sep 2022
-
-$14.30 M(-460.3%)
$326.03 M(-22.6%)
Jun 2022
-
$3.97 M(-96.7%)
$421.41 M(+7.8%)
Mar 2022
-
$121.74 M(-43.3%)
$391.07 M(+52.9%)
DateAnnualQuarterlyTTM
Dec 2021
$255.69 M(-759.5%)
$214.63 M(+164.7%)
$255.68 M(+862.0%)
Sep 2021
-
$81.07 M(-407.5%)
$26.58 M(-140.7%)
Jun 2021
-
-$26.37 M(+93.2%)
-$65.31 M(+41.7%)
Mar 2021
-
-$13.65 M(-5.7%)
-$46.07 M(+18.8%)
Dec 2020
-$38.77 M(+71.1%)
-$14.48 M(+33.9%)
-$38.77 M(+27.4%)
Sep 2020
-
-$10.81 M(+51.5%)
-$30.44 M(+16.5%)
Jun 2020
-
-$7.13 M(+12.4%)
-$26.13 M(+8.9%)
Mar 2020
-
-$6.35 M(+3.4%)
-$24.00 M(+5.9%)
Dec 2019
-$22.66 M(+29.7%)
-$6.14 M(-5.5%)
-$22.66 M(+37.2%)
Sep 2019
-
-$6.50 M(+29.9%)
-$16.52 M(+64.9%)
Jun 2019
-
-$5.00 M(-0.1%)
-$10.01 M(+99.9%)
Mar 2019
-
-$5.01 M
-$5.01 M
Dec 2018
-$17.48 M
-
-

FAQ

  • What is iTeos Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for iTeos Therapeutics?
  • What is iTeos Therapeutics annual EBITDA year-on-year change?
  • What is iTeos Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for iTeos Therapeutics?
  • What is iTeos Therapeutics quarterly EBITDA year-on-year change?
  • What is iTeos Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for iTeos Therapeutics?
  • What is iTeos Therapeutics TTM EBITDA year-on-year change?

What is iTeos Therapeutics annual EBITDA?

The current annual EBITDA of ITOS is -$153.09 M

What is the all time high annual EBITDA for iTeos Therapeutics?

iTeos Therapeutics all-time high annual EBITDA is $255.69 M

What is iTeos Therapeutics annual EBITDA year-on-year change?

Over the past year, ITOS annual EBITDA has changed by -$9.10 M (-6.32%)

What is iTeos Therapeutics quarterly EBITDA?

The current quarterly EBITDA of ITOS is -$47.78 M

What is the all time high quarterly EBITDA for iTeos Therapeutics?

iTeos Therapeutics all-time high quarterly EBITDA is $214.63 M

What is iTeos Therapeutics quarterly EBITDA year-on-year change?

Over the past year, ITOS quarterly EBITDA has changed by -$84.00 K (-0.18%)

What is iTeos Therapeutics TTM EBITDA?

The current TTM EBITDA of ITOS is -$153.09 M

What is the all time high TTM EBITDA for iTeos Therapeutics?

iTeos Therapeutics all-time high TTM EBITDA is $421.41 M

What is iTeos Therapeutics TTM EBITDA year-on-year change?

Over the past year, ITOS TTM EBITDA has changed by -$10.76 M (-7.56%)